Similarly, “ERBB2 signaling” and “ERBB2-ERBB3 signaling” pathways were identified from the boosted gene set, where HER2 and HER3 heterodimer signaling is vital for HER2-positive breast cancer by enhancing cell survival and proliferation [21]. This evidence concerns the gene ERBB3 and breast carcinoma.